跳至主要内容
临床试验/IRCT20210712051848N1
IRCT20210712051848N1已完成3 期

ocal Vancomycin Therapy to Reduce Surgical Site Infection in Spine Surgery: A Randomized Prospective Study

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 360 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
360

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • All patients over 18 years of age who underwent open spinal surgery in the cervical, thoracic and lumbosacral regions

排除标准

  • Previous history of spine infection
  • History of immunodeficiency or ongoing chemotherapy
  • History of kidney or liver failure
  • Allergy to vancomycin or cephalosporin
  • Inability to follow up to 3 months after surgery
  • Primary or metastatic spinal cord or spine tumors
  • Dissatisfaction with the study.

研究者

相似试验